[Glucocorticoid-induced osteoporosis in patients with rheumatoid arthritis and collagen diseases].
Sohen
Satoshi
S
Department of Orthopaedic Surgery and Rheumatology, Nara Hospital, Kinki University School of Medicine.
D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D018501:Antirheumatic Agents / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000150:complications* / Q000188:drug therapy; D001862:Bone Resorption / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D003095:Collagen Diseases / Q000150:complications* / Q000188:drug therapy; D016207:Cytokines / Q000502:physiology; D004164:Diphosphonates / Q000627:therapeutic use; D006023:Glycoproteins / Q000502:physiology; D006801:Humans; D018836:Inflammation Mediators / Q000502:physiology; D053590:Interleukin 1 Receptor Antagonist Protein; D053244:Osteoprotegerin; D011239:Prednisolone / Q000009:adverse effects*; D018160:Receptors, Cytoplasmic and Nuclear / Q000502:physiology; D017472:Receptors, Interleukin-1 / Q000037:antagonists & inhibitors / Q000502:physiology; D019947:Receptors, Interleukin-6 / Q000037:antagonists & inhibitors / Q000502:physiology; D018124:Receptors, Tumor Necrosis Factor; D011994:Recombinant Proteins / Q000627:therapeutic use; D012795:Sialoglycoproteins / Q000627:therapeutic use; D014409:Tumor Necrosis Factor-alpha / Q000276:immunology
D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D016207:Cytokines; D004164:Diphosphonates; D006023:Glycoproteins; C507763:IL1RN protein, human; D018836:Inflammation Mediators; D053590:Interleukin 1 Receptor Antagonist Protein; D053244:Osteoprotegerin; D018160:Receptors, Cytoplasmic and Nuclear; D017472:Receptors, Interleukin-1; D019947:Receptors, Interleukin-6; D018124:Receptors, Tumor Necrosis Factor; D011994:Recombinant Proteins; D012795:Sialoglycoproteins; C506030:TNFRSF11B protein, human; D014409:Tumor Necrosis Factor-alpha; D011239:Prednisolone